DRI Nagpur Seizes 3.01 Kg Of Amphetamine Drug Worth Rs 2.4 Crore, Arrests Two From Bus
The Directorate of Revenue Intelligence (DRI), Nagpur Regional Unit of Mumbai Zone, claimed to have dismantled an inter-state drug trafficking syndicate through the operation.
The contraband was concealed in three ladies' suits, which appeared to be unusually heavy, said the DRI Nagpur Regional Unit.
Acting on specific intelligence, officers of DRI Nagpur Regional Unit intercepted two passengers travelling by bus from Delhi to Bangalore, passing through Nagpur on October 28, 2026, on suspicion of carrying narcotic substances in their luggage, said a DRI statement.
The officers boarded the said bus at Bhagimari Toll Plaza on NH-47, Nagpur. They undertook a detailed examination of the passengers' luggage, which revealed that three ladies' suits appeared to be unusually heavy, it said.
On examination, white-coloured pouches concealed inside the suits were found to contain transparent polythene packets filled with a white crystalline substance, it said.
Field testing of representative samples, drawn separately from all three packets, gave a positive indication for the presence of amphetamine, the DRI said.
The three packets containing a total of 3.01 kg of amphetamine, with an illicit market value of approximately Rs 2.4 crore, were recovered from the two passengers and were subsequently seized under the relevant provisions of the NDPS Act, 1985, the DRI said.
The two passengers were arrested under the provisions of the NDPS Act, 1985 and were produced before the JFMC at Nagpur on September 29.
These sustained efforts against organised narcotics trafficking networks operating across state borders reflect the steadfast commitment of DRI towards combating drug trafficking and contributing to the Government of India's vision of a“Nasha Mukt Bharat”, said the statement.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment